Dexcom Rolls Out G7 CGM with Apple Watch Integration in U.S.

Dexcom announced its G7 continuous glucose monitoring (CGM) system now connects directly to the Apple Watch in the U.S., making it the first, only CGM available with Direct to Apple Watch.
 
The Dexcom G7 CGM uses its dedicated Bluetooth connection to send glucose info and personalized alerts to the user’s Apple Watch. G7 is the only CGM system that can display glucose readings on multiple devices simultaneously and independently, according to Dexcom. This includes a smartphone, smartwatch, receiver, or connected automated insulin delivery (AID) system.
 
Using Direct to Apple Watch, diabetes patients can track health metrics that can affect glucose level using Apple’s Activity, Cycle Tracking, Sleep, and other health features on Apple Watch, iPhone and iPad. This data is stored in the Health app, where it can be viewed with Dexcom G7 data that users choose to store in the Health app.
 
“At Dexcom, our users are at the heart of everything we do. Direct to Apple Watch has been one of our most requested features and we’re thrilled to roll it out to Dexcom G7 users in the U.S. and around the world,” said Jake Leach, executive VP and COO at Dexcom. “We’ve long believed that people with diabetes should be able to view their CGM data where and how they choose. Direct to Apple Watch is a testament to that, allowing people with diabetes flexibility and choice in how they manage their health.”
 
Direct to Apple Watch is now available to G7 users in the U.S., UK, and Ireland, with other markets launching later this month.
 
“Having used Direct to Apple Watch with Dexcom G7 for the last few months, being able to glance at my wrist and see my glucose levels in real-time has been a game changer,” said Dexcom Warrior Beth McDaniel of Northern Ireland. “For the first time since being diagnosed, I can leave my phone at home without worrying and enjoy my daily activities with the confidence that I have the information I need to help keep my diabetes under control.”